Shares of PURE Bioscience (OTCMKTS:PURE – Get Free Report) passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $0.07 and traded as low as $0.0621. PURE Bioscience shares last traded at $0.0686, with a volume of 36,910 shares trading hands.
PURE Bioscience Trading Down 8.4%
The firm has a 50 day simple moving average of $0.07 and a 200 day simple moving average of $0.07. The firm has a market capitalization of $8.92 million, a PE ratio of -3.43 and a beta of 0.33.
About PURE Bioscience
PURE Bioscience, Inc develops and commercializes antimicrobial products based on its proprietary silver dihydrogen citrate (SDC) technology. SDC is designed to provide broad-spectrum antimicrobial activity and is used as an active ingredient in formulations intended for applications such as surface disinfection, sanitation and odor control.
The company’s product portfolio has included PureGreen24, a disinfectant and sanitizer marketed for use on hard, nonporous surfaces in commercial, institutional, industrial and residential settings.
Featured Articles
- Five stocks we like better than PURE Bioscience
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
